Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 1 Conference is presently dedicated exclusively to Statistics in medicine.
Statistics refers to techniques of collecting, summarizing, and analysing data that are subject to random variation. The term is also applied to the data themselves and to summarizations of the data.
It is also a division of social medicine and the organization of public-Medical statistics includes population-health statistics and public-health organization statistics. The former studies in medico demographic process and dynamics of morbidity and physical development. The latter records and analyses statistics on medical networks.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
When a census is not feasible, a chosen subset of the population called a sample is studied. Once a sample that is representative of the population is determined, data is collected for the sample members in an observational or experimental setting. Again, descriptive statistics can be used to summarize the sample data. However, the drawing of the sample has been subject to an element of randomness, hence the established numerical descriptors from the sample are also due to uncertainty. In order to still draw meaningful conclusions about the entire population, inferential statistics is needed. It uses patterns in the sample data to draw inferences about the population represented, accounting for randomness. These inferences may take the form of: answering yes/no questions about the data (hypothesis testing), estimating numerical characteristics of the data (estimation), describing associations within the data (correlation) and modelling relationships within the data (for example, using regression analysis). Inference can extend to forecasting, prediction and estimation of unobserved values either in or associated with the population being studied; it can include extrapolation and interpolation of time series or spatial data, and can also include data mining.
In applying statistics to e.g. a scientific, industrial, or societal problem, it is necessary to begin with a population or process to be studied. Populations can be diverse topics such as "all persons living in a country" or "every atom composing a crystal".Ideally, statisticians compile data about the entire population (an operation called census). This may be organized by governmental statistical institutes. Descriptive statistics can be used to summarize the population data. Numerical descriptors include mean and standard deviation for continuous data types (like income), while frequency and percentage are more useful in terms of describing categorical data (like race).Medical research relies on Clinal trails to assess therapeutic benefits. Because of the effort and cost involved in these studies, investigators frequently use analyses of subgroups of study participants to extract as much information as possible. Such analyses, which assess the heterogeneity of treatment effects in subgroups of patients, may provide useful information for the care of patients and for future research. However, subgroup analyses also introduce analytic challenges and can lead to overstated and misleading results.National symposium and workshops provide participants with an advanced or updated review of the most novel and technological developments in research. The conference is unfastening to all delegates, industrialists, advertisers and directors of companies.
The top ten players are forecast to collectively lose share from 35% in 2013 to 30% in 2017, according to IMS. Patent expiries over the next few years will eat into the revenues of most companies during this period. Sanofi potential loss due to patent expiries is estimated to reach up to $8.1 billion. The company is then followed by Novartis, Roche, Astra-Zeneca and Eli Lilly with respectively potential losses of 7.7, 7.2, 6.7 and 6 billion dollars.
Companies of Statistical Software:
This page will be updated regularly.
This page was last updated on July 12, 2020